101 related articles for article (PubMed ID: 7944493)
1. [Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].
Noda K; Terajima Y; Ogita Y; Kono I; Hirabayashi K; Yakushiji M; Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2471-7. PubMed ID: 7944493
[TBL] [Abstract][Full Text] [Related]
2. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
[TBL] [Abstract][Full Text] [Related]
3. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
4. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
5. [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2453-60. PubMed ID: 7944491
[TBL] [Abstract][Full Text] [Related]
6. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
[TBL] [Abstract][Full Text] [Related]
7. [Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].
Yokoyama A; Kurita Y; Watanabe K; Negoro S; Ogura T; Nakano M; Minoda S; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2609-16. PubMed ID: 7979421
[TBL] [Abstract][Full Text] [Related]
8. [Late phase II trial of RP56976 (Docetaxel) in patients with non-small-cell lung cancer].
Onoshi T; Watanabe K; Furuse K; Kurita Y; Sugiura T; Sato K; Fujii M; Oizumi K; Abe S; Inoue Y
Gan To Kagaku Ryoho; 1995 Jan; 22(1):59-65. PubMed ID: 7826079
[TBL] [Abstract][Full Text] [Related]
9. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
Taguchi T; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1915-24. PubMed ID: 9797814
[TBL] [Abstract][Full Text] [Related]
10. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
11. [A phase II study of BMS-181339 in patients with ovarian cancer. BMS-181339 Ovarian Cancer Study Group].
Noda K; Ikeda M; Kudo R; Nishiya I; Yajima A; Tanaka K; Kodama S; Nozawa S; Taketani Y; Terashima Y
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2461-9. PubMed ID: 7944492
[TBL] [Abstract][Full Text] [Related]
12. [Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer].
Kudo S; Hino M; Fujita A; Igarashi T; Arita K; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2617-23. PubMed ID: 7979422
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of docetaxel in advanced soft tissue sarcomas.
Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
[TBL] [Abstract][Full Text] [Related]
14. [Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug].
Taguchi T; Furue H; Niitani H; Ishitani K; Kanamaru R; Hasegawa K; Ariyoshi Y; Noda K; Furuse K; Fukuoka M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1997-2005. PubMed ID: 7916183
[TBL] [Abstract][Full Text] [Related]
15. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion].
Noda K; Ikeda M; Kudo R; Nishiya I; Yajima A; Tanaka K; Kodama S; Takahashi T; Tokunaga A; Satoh I; Nozawa S; Taketani Y; Terashima Y; Isonishi S; Takeda Y; Nishijima M; Kuroshima Y; Fujii S; Izumi R; Tamaya T; Mori T; Okada H; Ogita S; Ozaki M; Hatae M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):317-25. PubMed ID: 8712825
[TBL] [Abstract][Full Text] [Related]
17. Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.
Fujiwara K; Kohno I; Tanaka K; Ogita S; Sasaki Y; Hirabayashi K; Yakushiji M; Tsunematsu R; Terashima Y; Taguchi T; Ohashi Y; Noda K
Anticancer Res; 1999; 19(1B):639-44. PubMed ID: 10216469
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese cooperative study.
Katsumata N; Tsunematsu R; Tanaka K; Terashima Y; Ogita S; Hoshiai H; Kohno I; Hirabayashi K; Yakushiji M; Noda K; Taguchi T
Ann Oncol; 2000 Dec; 11(12):1531-6. PubMed ID: 11205459
[TBL] [Abstract][Full Text] [Related]
19. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
[TBL] [Abstract][Full Text] [Related]
20. [A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers].
Takeuchi S; Dobashi K; Fujimoto S; Tanaka K; Suzuki M; Terashima Y; Hasumi K; Akiya K; Negishi Y; Tamaya T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1681-9. PubMed ID: 1872624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
